Rchr
J-GLOBAL ID：200901042080503370
Update date: Oct. 16, 2024
Tatetsu Hiro
タテツ ヒロ | Tatetsu Hiro
Affiliation and department：
Research field (1)：
Hematology and oncology
Research theme for competitive and other funds (3)：
- 2021 - 2024 骨髄異形成症候群に対する治療標的としてのSALL4の機能的解析
- 2017 - 2021 The role of SALL4 in myelodysplastic syndrome
- 2008 - 2009 Stratification of multiple myeloma according to PU.1 expression level
Papers (40)：
-
Shinya Endo, Nao Nishimura, Kosuke Toyoda, Yoshihiro Komohara, Joaquim Carreras, Hiromichi Yuki, Takafumi Shichijo, Shikiko Ueno, Niina Ueno, Shinya Hirata, et al. Decreased PU.1 expression in mature B cells induces lymphomagenesis. Cancer science. 2024
-
Takahisa Nakamura, Hiro Tatetsu, Yusuke Higuchi, Shinya Endo, Shinya Shiraishi, Koichi Kawanaka, Daisuke Imakane, Miyu Sonoda, Rie Furuta, Takafumi Shichijo, et al. Extranodal NK/T-cell lymphoma with localized relapse in bone marrow of lower leg detected using PET-CT. Journal of clinical and experimental hematopathology : JCEH. 2024. 64. 1. 45-51
-
Taichi Hirano, Hiro Tatetsu, Shikiko Ueno, Takafumi Shichijo, Shota Furukawa, Mizuho Tsujihashi, Toshikazu Miyakawa, Shinya Shiraishi, Yusuke Higuchi, Mitsuhiro Uchiba, et al. Significant response of patients with transformed follicular lymphoma with rapid disease progression to CAR-T therapy. Journal of clinical and experimental hematopathology : JCEH. 2023. 63. 4. 266-269
-
Hiro Tatetsu, Miho Watanabe, Jun Liu, Kenji Tokunaga, Eisaku Iwanaga, Yoshihiro Komohara, Emily Thrash, Mahmoud A Bassal, Masao Matsuoka, Daniel G Tenen, et al. Dissecting the cell of origin of aberrant SALL4 expression in myelodysplastic syndrome. Clinical and translational medicine. 2023. 13. 8. e1327
-
Takafumi Shichijo, Hiro Tatetsu, Kisato Nosaka, Yusuke Higuchi, Yoshitaka Kikukawa, Kosuke Toyoda, Shinya Shiraishi, Jun-Ichirou Yasunaga, Masao Matsuoka. Robust prognostic value of histologic transformation in patients with early progression of follicular lymphoma. Leukemia & lymphoma. 2023. 1-5
ｍore...
MISC (76)：
-
岡本祐毅, 高木あゆ美, 上野志貴子, 岩永栄作, 樋口悠介, 遠藤慎也, 徳永賢治, 立津央, 野坂生郷, 安永純一朗, et al. A case of CVID manifested after severe infections and drug hypersensitivity. 日本血液学会学術集会抄録(Web). 2021. 83rd
-
上野志貴子, 上野志貴子, 福吉葉子, 高木あゆ美, 内場光浩, 内場光浩, 野坂生郷, 立津央, 松岡雅雄, 米村雄士, et al. 輸血ガイドライン改訂前後による熊本大学病院での各科の輸血トリガー値の変化. 日本輸血細胞治療学会誌. 2021. 67. 2
-
崎田紫織, 崎田紫織, 福吉葉子, 福吉葉子, 石原綾子, 石原綾子, 和木由希美, 和木由希美, 川上ゆうか, 川上ゆうか, et al. 当院におけるHLA適合血小板製剤の使用状況と効果の検討. 日本輸血細胞治療学会誌. 2021. 67. 2
-
立津 央. 【造血器腫瘍の治療選択に関するエキスパートオピニオン】未治療低悪性度B細胞リンパ腫に対する化学療法の治療選択(CHOP、CVP、bendamustine). 血液内科. 2020. 80. 2. 180-185
-
工藤ひまり, 立津央, 今金大輔, 上野志貴子, 岩永栄作, 野坂生郷, 松岡雅雄. 進行性の神経障害をきたしたIgG型リンパ形質細胞性リンパ腫の1例. 日本血液学会学術集会抄録(Web). 2020. 82nd
ｍore...
Patents (1)：
Professional career (1)：
- Doctor of Medical Science (Kumamoto University)
Return to Previous Page
